Clinical trialNCT07675408Not, yet, recruitingInterventional

Validation of cueStim for Reduction of Freezing of Gait in Parkinson's Disease

SponsorFortis Medical Devices LimitedEnrollment60Parkinson's Disease With Freezing of Gait

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The goal of this clinical trial is to learn if the cueStim device can reduce the duration of freezing of gait (FoG) that occurs in patients with Parkinson's Disease. The study will compare two modes of operation of the cueStim device; both modes of operation use the same wearable device. The purpose of the study is to compare how the two modes affect symptoms across study participants. Because this is a research study, it is not yet known whether either mode reduces symptoms. Participants will: * Be randomized to one of the two modes available on the cueStim device * Wear the device for 4 weeks as they go about their daily life * Complete daily diary entries to document symptoms, falls and overall experience * Check-in with the clinical site throughout participation * Complete a final follow-up visit

clinicaltrials.gov ↗

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Parkinson'S Disease and Movement Disorders Center of Boca Raton
Boca Raton, Florida, United States
Stuart Isaacson, MD
Arrow Clinical Trials
Daytona Beach, Florida, United States
David Billmeier, MD
Emory University
Atlanta, Georgia, United States
Lucas McKay, PhD MSCR
University of Kansas
Kansas City, Kansas, United States
Kelvin Au, MD, FRCPC
Oregon Health and Science University
Portland, Oregon, United States
Martina Mancini, PhD
Evergreen Health Research Program
Kirkland, Washington, United States
Pinky Agarwal, MD, FAAN

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Oct 2026
Primary completion: 28 Feb 2027
Completion: 28 Feb 2027
Last update posted: 30 Jun 2026
Registered enrollment: 60
Registry id: NCT07675408

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.